| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Ablation of collagen VI leads to the release of platelets with altered function
|
Abbonante, Vittorio
|
|
|
5 |
23 |
p. 5150-5163
|
article
|
| 2 |
A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers
|
Lee, LaTasha H.
|
|
|
5 |
23 |
p. 5323-5331
|
article
|
| 3 |
Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma
|
Gebauer, Niklas
|
|
|
5 |
23 |
p. 5220-5225
|
article
|
| 4 |
ALCAM-EGFR interaction regulates myelomagenesis
|
Luo, Hongmei
|
|
|
5 |
23 |
p. 5269-5282
|
article
|
| 5 |
ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment
|
Chiu, Martina
|
|
|
5 |
23 |
p. 5164-5178
|
article
|
| 6 |
An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies
|
Roider, Tobias
|
|
|
5 |
23 |
p. 5060-5071
|
article
|
| 7 |
A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival
|
Lamaison, Claire
|
|
|
5 |
23 |
p. 5372-5386
|
article
|
| 8 |
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
|
Herrera, Alex F.
|
|
|
5 |
23 |
p. 5300-5311
|
article
|
| 9 |
Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F–induced disease
|
Müller, Peter
|
|
|
5 |
23 |
p. 5349-5359
|
article
|
| 10 |
ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology
|
Wood, William A.
|
|
|
5 |
23 |
p. 5429-5438
|
article
|
| 11 |
Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry
|
Bowers, Charles
|
|
|
5 |
23 |
p. 4969-4979
|
article
|
| 12 |
Association of race and ethnicity with clinical phenotype, genetics, and survival in pediatric acute myeloid leukemia
|
Conneely, Shannon E.
|
|
|
5 |
23 |
p. 4992-5001
|
article
|
| 13 |
AVEXIS technology identifies novel platelet-leukocyte binding partners including CD148-CD300a
|
Barroso, Ruben
|
|
|
5 |
23 |
p. 5016-5019
|
article
|
| 14 |
Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy
|
Kalot, Mohamad A.
|
|
|
5 |
23 |
p. 5023-5031
|
article
|
| 15 |
Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice
|
Herd, Oliver J.
|
|
|
5 |
23 |
p. 4877-4889
|
article
|
| 16 |
CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes
|
Huang, Benjamin J.
|
|
|
5 |
23 |
p. 4963-4968
|
article
|
| 17 |
Cleavage of talin by calpain promotes platelet-mediated fibrin clot contraction
|
Fong, Karen P.
|
|
|
5 |
23 |
p. 4901-4909
|
article
|
| 18 |
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia
|
Tiong, Ing S.
|
|
|
5 |
23 |
p. 5107-5111
|
article
|
| 19 |
Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia
|
Kater, Arnon P.
|
|
|
5 |
23 |
p. 5410-5414
|
article
|
| 20 |
CXCL12-abundant reticular cells are the major source of IL-6 upon LPS stimulation and thereby regulate hematopoiesis
|
Gerosa, Rahel C.
|
|
|
5 |
23 |
p. 5002-5015
|
article
|
| 21 |
Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency
|
Perez, Monika W.
|
|
|
5 |
23 |
p. 4864-4876
|
article
|
| 22 |
Differential sialic acid content in adult and neonatal fibrinogen mediates differences in clot polymerization dynamics
|
Nellenbach, Kimberly
|
|
|
5 |
23 |
p. 5202-5214
|
article
|
| 23 |
Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia
|
Li, Zhenhua
|
|
|
5 |
23 |
p. 5226-5238
|
article
|
| 24 |
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
|
Lambert, Juliette
|
|
|
5 |
23 |
p. 5258-5268
|
article
|
| 25 |
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
|
Bond, David A.
|
|
|
5 |
23 |
p. 5179-5189
|
article
|
| 26 |
Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial
|
Hsu, Peter
|
|
|
5 |
23 |
p. 5032-5040
|
article
|
| 27 |
Editorial Board
|
|
|
|
5 |
23 |
p. i
|
article
|
| 28 |
Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma
|
Frerichs, Kristine A.
|
|
|
5 |
23 |
p. 5128-5139
|
article
|
| 29 |
Engraftment characterization of risk-stratified AML in NSGS mice
|
Díaz de la Guardia, Rafael
|
|
|
5 |
23 |
p. 4842-4854
|
article
|
| 30 |
Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage
|
Leich, Ellen
|
|
|
5 |
23 |
p. 4890-4900
|
article
|
| 31 |
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma
|
Pighi, Chiara
|
|
|
5 |
23 |
p. 5239-5257
|
article
|
| 32 |
GDP/GTP exchange factor MADD drives activation and recruitment of secretory Rab GTPases to Weibel-Palade bodies
|
Kat, Marije
|
|
|
5 |
23 |
p. 5116-5127
|
article
|
| 33 |
Genome-wide whole-blood transcriptome profiling across inherited bone marrow failure subtypes
|
Walne, Amanda J.
|
|
|
5 |
23 |
p. 5360-5371
|
article
|
| 34 |
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
|
McCall, David
|
|
|
5 |
23 |
p. 5215-5219
|
article
|
| 35 |
Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia
|
Zavorka Thomas, Megan E.
|
|
|
5 |
23 |
p. 5041-5046
|
article
|
| 36 |
Hapln1b, a central organizer of the ECM, modulates kit signaling to control developmental hematopoiesis in zebrafish
|
Mahony, Christopher B.
|
|
|
5 |
23 |
p. 4935-4948
|
article
|
| 37 |
HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins
|
Jiang, Xiaoyu
|
|
|
5 |
23 |
p. 5072-5085
|
article
|
| 38 |
Human iPSC-derived macrophages for efficient Staphylococcus aureus clearance in a murine pulmonary infection model
|
Rafiei Hashtchin, Anna
|
|
|
5 |
23 |
p. 5190-5201
|
article
|
| 39 |
Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
|
Wang, Ying
|
|
|
5 |
23 |
p. 5290-5299
|
article
|
| 40 |
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
|
Maurer, Katie
|
|
|
5 |
23 |
p. 5140-5149
|
article
|
| 41 |
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported
|
Anekpuritanang, Tauangtham
|
|
|
5 |
23 |
p. 5057-5059
|
article
|
| 42 |
Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
|
Verneris, Michael R.
|
|
|
5 |
23 |
p. 5387-5395
|
article
|
| 43 |
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
|
Mikkilineni, Lekha
|
|
|
5 |
23 |
p. 5312-5322
|
article
|
| 44 |
Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia
|
Leung, Halina H.L.
|
|
|
5 |
23 |
p. 5439-5451
|
article
|
| 45 |
Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies
|
Davids, Matthew S.
|
|
|
5 |
23 |
p. 5332-5343
|
article
|
| 46 |
Investigational curative gene therapy approaches to sickle cell disease
|
Williams, David A.
|
|
|
5 |
23 |
p. 5452
|
article
|
| 47 |
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant
|
Chihara, Dai
|
|
|
5 |
23 |
p. 4807-4816
|
article
|
| 48 |
Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma
|
Kennedy, Vanessa E.
|
|
|
5 |
23 |
p. 5344-5348
|
article
|
| 49 |
NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
|
Yoshida, Masanori
|
|
|
5 |
23 |
p. 5420-5428
|
article
|
| 50 |
Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
|
Richard-Carpentier, Guillaume
|
|
|
5 |
23 |
p. 5415-5419
|
article
|
| 51 |
PD-1 inhibition in advanced myeloproliferative neoplasms
|
Hobbs, Gabriela
|
|
|
5 |
23 |
p. 5086-5097
|
article
|
| 52 |
Platelet FcγRIIA-induced serotonin release exacerbates the severity of transfusion-related acute lung injury in mice
|
El Mdawar, Marie-Belle
|
|
|
5 |
23 |
p. 4817-4830
|
article
|
| 53 |
Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation
|
Ren, Xiying
|
|
|
5 |
23 |
p. 4910-4921
|
article
|
| 54 |
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
|
Horwitz, Steven M.
|
|
|
5 |
23 |
p. 5098-5106
|
article
|
| 55 |
Redundant mechanisms driven independently by RUNX1 and GATA2 for hematopoietic development
|
Bresciani, Erica
|
|
|
5 |
23 |
p. 4949-4962
|
article
|
| 56 |
Regulatory association of long noncoding RNAs and chromatin accessibility facilitates erythroid differentiation
|
Ren, Yunxiao
|
|
|
5 |
23 |
p. 5396-5409
|
article
|
| 57 |
Restriction of HIV-1 infection in sickle cell trait
|
Kumari, Namita
|
|
|
5 |
23 |
p. 4922-4934
|
article
|
| 58 |
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL
|
Miller, Jemima H.
|
|
|
5 |
23 |
p. 5112-5115
|
article
|
| 59 |
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis
|
Fanikos, John
|
|
|
5 |
23 |
p. 5283-5289
|
article
|
| 60 |
Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion
|
Ebraheem, Mohammad S.
|
|
|
5 |
23 |
p. 5020-5022
|
article
|
| 61 |
The immunometabolite itaconate inhibits heme synthesis and remodels cellular metabolism in erythroid precursors
|
Marcero, Jason R.
|
|
|
5 |
23 |
p. 4831-4841
|
article
|
| 62 |
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
|
Thudium Mueller, Karen
|
|
|
5 |
23 |
p. 4980-4991
|
article
|
| 63 |
Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel
|
Pavlovsky, Carolina
|
|
|
5 |
23 |
p. 4855-4863
|
article
|
| 64 |
Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
|
Magenau, John M.
|
|
|
5 |
23 |
p. 5047-5056
|
article
|
Journal description